The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Evidence for a human-specific mechanism for diet and antibody-mediated inflammation in carcinoma progression
Open accessAbstract
Patients with cancer have circulating heterophile antibodies that agglutinate animal red cells via recognition of the mammalian cell surface sialic acid N-glycolylneuraminic acid (Neu5Gc), which was long considered an oncofetal antigen in humans. However, humans are genetically deficient in Neu5Gc production and instead metabolically accumulate Neu5Gc from dietary sources, particularly red meats and milk products. Moreover, mice with a human-like defect showed no alternate pathway for Neu5Gc synthesis and even normal humans express anti-Neu5Gc antibodies. We show here that human tumors accumulate Neu5Gc that is covalently attached to multiple classes of glycans. The paradox of human tumor Neu5Gc accumulation in the face of circulating anti-Neu5Gc antibodies was hypothesized to be due to facilitation of tumor progression by the resulting low-grade chronic inflammation. Indeed, murine tumors expressing human-like levels of Neu5Gc show accelerated growth in syngeneic mice with a human-like Neu5Gc deficiency, coincident with the induction of anti-Neu5Gc antibodies and increased infiltration of inflammatory cells. Transfer of polyclonal monospecific syngeneic mouse anti-Neu5Gc serum also enhanced growth of transplanted syngeneic tumors bearing human-like levels of Neu5Gc, with tumors showing evidence for antibody deposition, enhanced angiogenesis and chronic inflammation. These effects were suppressed by a cyclooxygenase-2 inhibitor, a drug type known to reduce human carcinoma risk. Finally, affinity-purified human anti-Neu5Gc antibodies also accelerate growth of Neu5Gc-containing tumors in Neu5Gc-deficient mice. Taken together, the data suggest that the human propensity to develop diet-related carcinomas is contributed to by local chronic inflammation, resulting from interaction of metabolically-accumulated dietary Neu5Gc with circulating anti-Neu5Gc antibodies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399 · cited 1×
“Indeed, many cancers are associated with chronic inflammation (29, 32–34), and there is good evidence from others that chronic activation of innate immune cells can promote carcinogenesis (30, 32).”
BackgroundA cytokine-mediated link between innate immunity, inflammation, and cancer
Lin, W.-W., & Karin, M. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31537 · Cited by 1,940 · cited 1×
“Other inflammatory mechanisms involving cytokines and the NFkappa-B pathway are also clearly implicated in carcinogenesis and tumor progression (48, 49).”
BackgroundThe wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer
Naugler, W. E., & Karin, M. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.12.007 · Cited by 730 · cited 1×
“Other inflammatory mechanisms involving cytokines and the NFkappa-B pathway are also clearly implicated in carcinogenesis and tumor progression (48, 49).”
BackgroundFraser, G. E. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/70.3.532s · Cited by 489
Key, T. J., Fraser, G. E., Thorogood, M., Appleby, P. N., Beral, V., Reeves, G., Burr, M. L., Chang-Claude, J., Frentzel-Beyme, R., Kuzma, J. W., et al. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/70.3.516s · Cited by 484
Cited by
Nathan, C., & Ding, A. (2010) · Cell · doi:10.1016/j.cell.2010.02.029 · Cited by 2,183
Advances in the Biology and Chemistry of Sialic Acids
Chen, X., & Varki, A. (2010) · ACS Chemical Biology · doi:10.1021/cb900266r · Cited by 543
Self-citationSialic acids in cancer biology and immunity
Pearce, O. M. T., & Läubli, H. (2016) · Glycobiology · doi:10.1093/glycob/cwv097 · Cited by 470
Emerging principles for the therapeutic exploitation of glycosylation
Dalziel, M., Crispin, M., Scanlan, C. N., Zitzmann, N., & Dwek, R. A. (2014) · Science · doi:10.1126/science.1235681 · Cited by 447
A red meat-derived glycan promotes inflammation and cancer progression
Samraj, A. N., Pearce, O. M. T., Läubli, H., Crittenden, A. N., Bergfeld, A. K., Banda, K., Gregg, C. J., Bingman, A. E., Secrest, P., Diaz, S. L., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1417508112 · Cited by 407
Self-citationFinch, C. E. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909606106 · Cited by 407
Implications of the presence of N-glycolylneuraminic acid in recombinant therapeutic glycoproteins
Ghaderi, D., Taylor, R. E., Padler-Karavani, V., Diaz, S., & Varki, A. (2010) · Nature Biotechnology · doi:10.1038/nbt.1651 · Cited by 372
Self-citationGhaderi, D., Zhang, M., Hurtado-Ziola, N., & Varki, A. (2012) · Biotechnology and Genetic Engineering Reviews · doi:10.5661/bger-28-147 · Cited by 320
“…Neu5Gc has been unambiguously detected in several malignant human tumors by various immunological and chemical techniques (Malykh et al., 2001; Hedlund et al., 2008) and in much smaller amounts even in normal human epithelial and endothelial cells (Tangvoranuntakul et al., 2003; Hedlund et…”
BackgroundInfluentialSelf-citationExploration of the Sialic Acid World
(2018) · Advances in Carbohydrate Chemistry and Biochemistry · doi:10.1016/bs.accb.2018.09.001 · Cited by 320
Metabolic glycoengineering: Sialic acid and beyond
Du, J., Meledeo, M. A., Wang, Z., Khanna, H. S., Paruchuri, V. D. P., & Yarema, K. J. (2009) · Glycobiology · doi:10.1093/glycob/cwp115 · Cited by 299
Meat: The balance between nutrition and health. A review
De Smet, S., & Vossen, E. (2016) · Meat Science · doi:10.1016/j.meatsci.2016.04.008 · Cited by 296
Milk intelligence: Mining milk for bioactive substances associated with human health
Mills, S., Ross, R. P., Hill, C., Fitzgerald, G. F., & Stanton, C. (2011) · International Dairy Journal · doi:10.1016/j.idairyj.2010.12.011 · Cited by 278
Uniquely human evolution of sialic acid genetics and biology
Varki, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914634107 · Cited by 278
Self-citationSimple Sugars to Complex Disease—Mucin-Type O-Glycans in Cancer
(2015) · Advances in Cancer Research · doi:10.1016/bs.acr.2014.11.002 · Cited by 260
Involvement of a Non-Human Sialic Acid in Human Cancer
Samraj, A. N., Läubli, H., Varki, N., & Varki, A. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00033 · Cited by 196
Self-citationPotential impact of the non‐human sialic acid N‐glycolylneuraminic acid on transplant rejection risk
Padler‐Karavani, V., & Varki, A. (2011) · Xenotransplantation · doi:10.1111/j.1399-3089.2011.00622.x · Cited by 162
“, chronic inflammation–mediated tumor growth stimulation and exacerbation of vascular disease [16,17].”
BackgroundSelf-citationAlisson-Silva, F., Kawanishi, K., & Varki, A. (2016) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2016.07.002 · Cited by 156
Self-citationAbsence of Neu5Gc and Presence of Anti-Neu5Gc Antibodies in Humans—An Evolutionary Perspective
Altman, M. O., & Gagneux, P. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00789 · Cited by 112
Characterization of immunogenic Neu5Gc in bioprosthetic heart valves
Reuven, E. M., Leviatan Ben‐Arye, S., Marshanski, T., Breimer, M. E., Yu, H., Fellah‐Hebia, I., Roussel, J., Costa, C., Galiñanes, M., Mañez, R., et al. (2016) · Xenotransplantation · doi:10.1111/xen.12260 · Cited by 80
Self-citationWhy Is N-Glycolylneuraminic Acid Rare in the Vertebrate Brain?
Davies, L. R. L., & Varki, A. (2013) · Topics in Current Chemistry · doi:10.1007/128_2013_419 · Cited by 80
Self-citationGlycosylated Biotherapeutics: Immunological Effects of N-Glycolylneuraminic Acid
Yehuda, S., & Padler-Karavani, V. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00021 · Cited by 71
Self-citationGlycoengineering in CHO cells: advances in systems biology
Tejwani, V., Andersen, M. R., Nam, J. H., & Sharfstein, S. T. (2018) · Biotechnology Journal · doi:10.1002/biot.201700234 · Cited by 70
The Possible Role of Anti-Neu5Gc as an Obstacle in Xenotransplantation
Tector, A. J., Mosser, M., Tector, M., & Bach, J.-M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00622 · Cited by 60
Lee, J.-G., Lee, S., Jeon, J., Kong, H. G., Cho, H.-J., Kim, J.-H., Kim, S.-Y., Oh, M. J., Lee, D., Seo, N., et al. (2022) · Microbiome · doi:10.1186/s40168-021-01191-x · Cited by 26
Metadata
- Authors
- Hedlund, M., Padler-Karavani, V., Varki, N. M., & Varki, A.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2008-12-02
- Volume
- 105
- Issue
- 48
- Pages
- 18936-18941
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2110649539
- Cited by
- 199
- References
- 5
- FWCI
- 3.35
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.